Multi-level barriers and facilitators to implementing evidence-based antipsychotics in the treatment of early-phase schizophrenia
Results may guide implementation strategy selection for future programs seeking to optimize the use of LAI antipsychotics and clozapine for early-phase schizophrenia, when appropriate.
Authors
- C. Hendricks Brown (ORCID: https://orcid.org/0000-0002-0294-2419)
- Delbert G. Robinson (ORCID: https://orcid.org/0000-0001-6606-4507)
- John M. Kane (ORCID: https://orcid.org/0000-0002-2628-9442)
- Jennifer Bannon (ORCID: https://orcid.org/0000-0002-1588-3665)
- Allison J. Carroll (ORCID: https://orcid.org/0000-0002-3576-8808)
- Theresa L. Walunas (ORCID: https://orcid.org/0000-0002-7653-3650)
- Avram Kordon
Institutions
- Northwestern University (US)
- Northwell Health (US)
- Feinstein Institute for Medical Research (US)
- Donald & Barbara Zucker School of Medicine at Hofstra/Northwell (US)
Publication Details
- Journal
- Frontiers in Health Services
- Published
- 2024-10-14
- DOI
- https://doi.org/10.3389/frhs.2024.1385398
- Citations
- 4
- Primary Topic
- Schizophrenia research and treatment
- Type
- article
- Field-Weighted Citation Impact
- 1.16
Funders
- National Institute of Mental Health